Literature DB >> 9665412

CA 125 in ovarian cancer: advances and controversy.

H A Fritsche, R C Bast.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9665412

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  26 in total

Review 1.  Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer.

Authors:  Ajay P Singh; Shantibhusan Senapati; Moorthy P Ponnusamy; Maneesh Jain; Subodh M Lele; John S Davis; Steven Remmenga; Surinder K Batra
Journal:  Lancet Oncol       Date:  2008-11       Impact factor: 41.316

2.  Successful eradication of established peritoneal ovarian tumors in SCID-Beige mice following adoptive transfer of T cells genetically targeted to the MUC16 antigen.

Authors:  Alena A Chekmasova; Thapi D Rao; Yan Nikhamin; Kay J Park; Douglas A Levine; David R Spriggs; Renier J Brentjens
Journal:  Clin Cancer Res       Date:  2010-07-13       Impact factor: 12.531

3.  Migration dynamics of ovarian epithelial cells on micro-fabricated image-based models of normal and malignant stroma.

Authors:  Samuel Alkmin; Rebecca Brodziski; Haleigh Simon; Daniel Hinton; Randall H Goldsmith; Manish Patankar; Paul J Campagnola
Journal:  Acta Biomater       Date:  2019-09-27       Impact factor: 8.947

4.  HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases.

Authors:  Rafael Molina; Jose M Escudero; Jose M Augé; Xavier Filella; Laura Foj; Aureli Torné; Jose Lejarcegui; Jaume Pahisa
Journal:  Tumour Biol       Date:  2011-08-24

5.  E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium.

Authors:  N Auersperg; J Pan; B D Grove; T Peterson; J Fisher; S Maines-Bandiera; A Somasiri; C D Roskelley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

6.  Ovarian cancer screening and early detection in the general population.

Authors:  Jose A Rauh-Hain; Thomas C Krivak; Marcela G Del Carmen; Alexander B Olawaiye
Journal:  Rev Obstet Gynecol       Date:  2011

7.  Upregulation of Poly (ADP-Ribose) Polymerase-1 (PARP1) in Triple-Negative Breast Cancer and Other Primary Human Tumor Types.

Authors:  Valeria Ossovskaya; Ingrid Chou Koo; Eric P Kaldjian; Christopher Alvares; Barry M Sherman
Journal:  Genes Cancer       Date:  2010-08

8.  Treatment monitoring of patients with epithelial ovarian cancer using invasive circulating tumor cells (iCTCs).

Authors:  Michael L Pearl; Huan Dong; Shaun Tulley; Qiang Zhao; Marc Golightly; Stanley Zucker; Wen-Tien Chen
Journal:  Gynecol Oncol       Date:  2015-03-11       Impact factor: 5.482

Review 9.  Current status of mucins in the diagnosis and therapy of cancer.

Authors:  Satyanarayana Rachagani; Maria P Torres; Nicolas Moniaux; Surinder K Batra
Journal:  Biofactors       Date:  2009 Nov-Dec       Impact factor: 6.113

10.  Mucins in ovarian cancer diagnosis and therapy.

Authors:  Subhash C Chauhan; Deepak Kumar; Meena Jaggi
Journal:  J Ovarian Res       Date:  2009-12-24       Impact factor: 4.234
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.